20 Stocks Moving in Monday’s Pre-Market Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) rose 32.1% to $4.53 in pre-market trading.
Biotech Pluristem, Israel-Based Tnuva Collaborate On Cultured Food Platform
Pluristem Therapeutics Inc (NASDAQ: PSTI) and Tnuva Group have collaborated to develop, manufacture and commercialize cultured cell-based products for the food industry.
51 Biggest Movers From Yesterday
Gainers
Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
Pluristem Reports Results From Its Phase II Studies Of Acute Respiratory Distress Syndrome Associated With COVID-19 Did Not Meet The Primary Efficacy Endpoint Of Statistically Significant Improvement Of VFD At 28 Days
Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI) (the "Company"), a leading biotechnology company, today announced topline results from its Phase II dose escalation studies evaluating the safety and
From Benzinga’s Global Small Cap Conference: Pluristem Therapeutics President & CEO, Yaky Yanay Says Co Has $80 Million Cash On Hand
https://www.youtube.com/watch?v=XkOilNZqoEI
From Benzinga’s Global Small Cap Conference: Pluristem Therapeutics President & CEO, Yaky Yanay Begins Presenting
https://www.youtube.com/watch?v=XkOilNZqoEI
Pluristem Completes Enrollment Of Its Multinational Phase III Study Of Muscle Regeneration Following Hip Fracture Surgery
Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI) (the "Company"), a leading biotechnologycompany announced today that its multinational Phase IIImulticenter, randomized, double-blind,